Literature DB >> 27098906

Rheumatoid arthritis: Features of synovium in RA remission revealed.

Joanna Collison.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27098906     DOI： 10.1038/nrrheum.2016.63

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission.

Authors:  Julio Ramírez; Raquel Celis; Alicia Usategui; Virginia Ruiz-Esquide; Regina Faré; Andrea Cuervo; Raimon Sanmartí; José L Pablos; Juan D Cañete
Journal:  Arthritis Res Ther       Date:  2016-03-31       Impact factor: 5.156
  1 in total
  4 in total

Review 1.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

2.  lncRNAS56464.1 as a ceRNA promotes the proliferation of fibroblast‑like synoviocytes in experimental arthritis via the Wnt signaling pathway and sponges miR‑152‑3p.

Authors:  Hui Jiang; Jian Liu; Chang Fan; Jing Wang; Weiping Li
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

3.  Synovial fibroblast-targeting liposomes encapsulating an NF-κB-blocking peptide ameliorates zymosan-induced synovial inflammation.

Authors:  Changcheng You; Jianing Zu; Xiaoqi Liu; Pengyu Kong; Chengchao Song; Rongzhi Wei; Changlong Zhou; Yufu Wang; Jinglong Yan
Journal:  J Cell Mol Med       Date:  2018-01-30       Impact factor: 5.310

4.  Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis.

Authors:  Kai Guo; Xin Bu; Chongfei Yang; Xiaorui Cao; Huan Bian; Qingsheng Zhu; Jinyu Zhu; Dawei Zhang
Journal:  Front Immunol       Date:  2019-01-10       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.